Previous studies focused on the relationship between dyslipidemia and estrogen deficiency in postmenopausal women, but latest studies have found that endogenous estrogens were not independent predictors.[3] We all know that the level of estrogen is generally low in postmenopausal women, but the level of follicle stimulating hormone (FSH) is variable, especially in obese and lean women. Here, BRD2 is linked to metabolic syndrome.